Literature DB >> 7815308

The Bateman function revisited: a critical reevaluation of the quantitative expressions to characterize concentrations in the one compartment body model as a function of time with first-order invasion and first-order elimination.

E R Garrett1.   

Abstract

The Bateman function, A"(e-k(e)t--e-k(a)t), quantifies the time course of a first-order invasion (rate constant ka) to, and a first-order elimination (rate constant ke) from, a one-compartment body model where A" = (gamma Dose)ka/(ka-ke)V. The rate constants (when ka > 3ke) are frequently determined by the "method of residuals" or "feathering." The rate constant ka is actually the sum of rate constants for the removal of drug from the invading compartment. "Flip-flop," the interchange of the values of the evaluated rate constants, occurs when ke > 3ka. Whether -ka or -ke is estimable from the terminal ln C-t slope can be determined from which apparent volume of distribution, V, derived from the Bateman function is the most reasonable. The Bateman function and "feathering" fail when the rate constants are equal. The time course is then expressed by C = gamma Dtk e-kt. The determination of such equal k values can be obtained by the nonlinear fitting of such C-t data with random error to the Bateman function. Also, rate constant equality can be concluded when 1/tmax and the kmin (value of ke at the minimum value of ek(e)tmax/ke plotted against variable ke values) are synonymous or when kmintmax approximates unity. Simpler methods exist to evaluate C-t data. When a drug has 100% bioavailability, regression of Dose/V/C on AUC/C in the nonabsorption phase gives ke no matter what is the ratio of m = ka/ke. Since k(e)tmax = ln m/(m-1), m can be determined from the given table relating m and k(e)tmax. When gamma is unknown, ke can be estimated from the abscissas of intersections of plots of Cmax ek(e)tmax and keAUC, both plotted vs. arbitrary values of ke, and gamma D/V values are estimable from the ordinate of the intersection. Also, when gamma is unknown, ke can be estimated from the abscissas of intersections (or of closest approaches) of ek(e)tmax/ke and AUC/Cmax, both plotted vs. arbitrary values of ke. The C-t plot of the Modified Bateman function, C = Be-lambda 2t-A e-lambda 1t, does not commence at the origin (i.e., when tc = 0 = 0 and when a lag time does not exist).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7815308     DOI: 10.1007/bf02353538

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  11 in total

1.  STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: A COMPARISON OF THE PHARMACODYNAMICS OF DICUMAROL AND WARFARIN IN MAN.

Authors:  R A O'REILLY; P M AGGELER; L S LEONG
Journal:  Thromb Diath Haemorrh       Date:  1964-04-15

2.  Per cent absorbed time plots derived from blood level and/or urinary excretion data.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1963-06       Impact factor: 3.534

3.  On the assessment of the relative magnitude of rate constants in the linear open one-compartment model.

Authors:  P Macheras; M Symillides; C Reppas
Journal:  J Pharm Sci       Date:  1992-12       Impact factor: 3.534

4.  Kinetics of diphenylhydantoin elimination in rats.

Authors:  J J Ashley; G Levy
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

5.  Effect of parallel first-order loss from site of administration on calculated values for absorption rate constants.

Authors:  R E Notari; J L DeYoung; R H Reuning
Journal:  J Pharm Sci       Date:  1972-01       Impact factor: 3.534

6.  Simplified methods for the evaluation of the parameters of the time course of plasma concentration in the one-compartment body model with first-order invasion and first-order drug elimination including methods for ascertaining when such rate constants are equal.

Authors:  E R Garrett
Journal:  J Pharmacokinet Biopharm       Date:  1993-12

7.  Concentration ratio method to determine the rate constant for the special case when ka = ke.

Authors:  I H Patel
Journal:  J Pharm Sci       Date:  1984-06       Impact factor: 3.534

8.  Nonlinear regression approach for determining whether absorption and elimination rate constants are equal in the one-compartment open model with first-order processes.

Authors:  K K Chan; K W Miller
Journal:  J Pharm Sci       Date:  1983-05       Impact factor: 3.534

9.  A pharmacokinetic analysis program (multi) for microcomputer.

Authors:  K Yamaoka; Y Tanigawara; T Nakagawa; T Uno
Journal:  J Pharmacobiodyn       Date:  1981-11

10.  A simple method for determining whether absorption and elimination rate constants are equal in the one-compartment open model with first-order processes.

Authors:  M Bialer
Journal:  J Pharmacokinet Biopharm       Date:  1980-02
View more
  19 in total

Review 1.  Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development.

Authors:  Jaime A Yáñez; Connie M Remsberg; Casey L Sayre; M Laird Forrest; Neal M Davies
Journal:  Ther Deliv       Date:  2011-05

2.  Parameterisation affects identifiability of population models.

Authors:  Vittal Shivva; Julia Korell; Ian G Tucker; Stephen B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-12-31       Impact factor: 2.745

Review 3.  Link between a high k on for drug binding and a fast clinical action: to be or not to be?

Authors:  Georges Vauquelin
Journal:  Medchemcomm       Date:  2018-08-16       Impact factor: 3.597

4.  Effects of target binding kinetics on in vivo drug efficacy: koff , kon and rebinding.

Authors:  Georges Vauquelin
Journal:  Br J Pharmacol       Date:  2016-07-04       Impact factor: 8.739

5.  Pharmacokinetic-pharmacodynamic modeling of the inhibitory effects of naproxen on the time-courses of inflammatory pain, fever, and the ex vivo synthesis of TXB2 and PGE2 in rats.

Authors:  Elke H J Krekels; Marie Angesjö; Ingemo Sjögren; Kristina Angeby Möller; Odd-Geir Berge; Sandra A G Visser
Journal:  Pharm Res       Date:  2011-02-23       Impact factor: 4.200

6.  Distinct in vivo target occupancy by bivalent- and induced-fit-like binding drugs.

Authors:  Georges Vauquelin
Journal:  Br J Pharmacol       Date:  2017-10-18       Impact factor: 8.739

7.  Electrodermal Activity for Measuring Cognitive and Emotional Stress Level.

Authors:  Osmalina Nur Rahma; Alfian Pramudita Putra; Akif Rahmatillah; Yang Sa'ada Kamila Ariyansah Putri; Nuzula Dwi Fajriaty; Khusnul Ain; Rifai Chai
Journal:  J Med Signals Sens       Date:  2022-05-12

8.  Self-collected urine sampling to study the kinetics of urinary toluene (and o-cresol) and define the best sampling time for biomonitoring.

Authors:  Silvia Fustinoni; Rosa Mercadante; Laura Campo
Journal:  Int Arch Occup Environ Health       Date:  2009-01-06       Impact factor: 3.015

9.  An approach for identifiability of population pharmacokinetic-pharmacodynamic models.

Authors:  V Shivva; J Korell; I G Tucker; S B Duffull
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-06-19

10.  Decomposition of skin conductance data by means of nonnegative deconvolution.

Authors:  Mathias Benedek; Christian Kaernbach
Journal:  Psychophysiology       Date:  2010-03-05       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.